NCT01774838View on ClinicalTrials.gov

Vasoactive and Anti-inflammatory Effects of Prasugrel in Acute Coronary Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Acute Coronary SyndromeUnstable Angina
Interventions
DRUG

Prasugrel

3 months treatment

DRUG

Clopidogrel

3 months treatment

Trial Locations (1)

50937

Cardiology, University Hospital of Cologne, Cologne

All Listed Sponsors
lead

University of Cologne

OTHER

NCT01774838 - Vasoactive and Anti-inflammatory Effects of Prasugrel in Acute Coronary Syndrome | Biotech Hunter | Biotech Hunter